SCHEMBL7337643

SCHEMBL7337643

COc1ccc(C[Si](C)(C)CCl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.48
GSK3A P49840 1/20 0.47
GSK3B P49841 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
ALDH1A1 P00352 5/20 0.46
ALOX15 P16050 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
CMA1 P23946 1/20 0.46
AGXT P21549 2/20 0.45
LTA4H P09960 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
CYP2D6 P10635 1/20 0.44
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29065724 0.83 IDO1 (0.48) IDO1GSK3AGSK3BCA12CA1
SCHEMBL9075896 0.82 TAAR1 (0.53) IDO1CA12CA1CA2CA7
SCHEMBL9384544 0.81 IDO1 (0.50) IDO1GSK3AGSK3BCA12CA1
SCHEMBL5305930 0.81 IDO1 (0.50) IDO1GSK3AGSK3BCA12CA1
SCHEMBL5574984 0.80 IDO1 (0.54) IDO1CA12CA1CA2CA7
SCHEMBL297636 0.78 IDO1 (0.52) IDO1GSK3AGSK3BCA12CA1
SCHEMBL9615514 0.77 IDO1 (0.50) IDO1CA12CA1CA2CA7
SCHEMBL7333275 0.76 IDO1 (0.42) IDO1ALDH1A1MAPTAGXTTAAR1
SCHEMBL7337431 0.76 MGLL (0.42) CA2ALDH1A1TAAR1SMN1; SMN2ATM
SCHEMBL7338557 0.76 IDO1 (0.42) IDO1ALDH1A1KDM4EMAPTAGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1216921-A Method for inducing vascular cell adhesion molecule-1 and treating chronic inflammatory diseases using 2, 6-dialkyl-4-silyl-phenols HOECHST MARION ROUSSEL INC (US) 1999-05-19 CN disclosed
EP-0910384-A1 METHOD OF INHIBITING VASCULAR CELL ADHESION MOLECULE-1 AND TREATING CHRONIC INFLAMMATORY DISEASES WITH 2,6-DI-ALKYL-4-SILYL-PHENOLS HOECHST MARION ROUSSEL, INC. (US) 1999-04-28 EP disclosed
US-5795876-A ANTIINFLAMMATORY AGENTS HOECHST MARION ROUSSSEL, INC. (US) 1998-08-18 US disclosed
WO-1997040837-A1 METHOD OF INHIBITING VASCULAR CELL ADHESION MOLECULE-1 AND TREATING CHRONIC INFLAMMATORY DISEASES WITH 2,6-DI-ALKYL-4-SILYL-PHENOLS HOECHST MARION ROUSSEL, INC. (US) 1997-11-06 WO disclosed
EP-0468825-B1 Organosilane derivatives, pharmaceutical compositions containing them and process for preparing same RICHTER GEDEON VEGYESZET (HU) 1997-01-08 EP disclosed
US-5340823-A Administering a muscle relaxants for treating parkinson*s disease RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1994-08-23 US disclosed
US-5198446-A Muscle Relaxants RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1993-03-30 US disclosed
EP-0468825-A1 Organosilane derivatives, pharmaceutical compositions containing them and process for preparing same Richter Gedeon Vegyészeti Gyár R.T. (HU) 1992-01-29 EP disclosed